JP2022513590A5 - - Google Patents
Info
- Publication number
- JP2022513590A5 JP2022513590A5 JP2021524277A JP2021524277A JP2022513590A5 JP 2022513590 A5 JP2022513590 A5 JP 2022513590A5 JP 2021524277 A JP2021524277 A JP 2021524277A JP 2021524277 A JP2021524277 A JP 2021524277A JP 2022513590 A5 JP2022513590 A5 JP 2022513590A5
- Authority
- JP
- Japan
- Prior art keywords
- transplant rejection
- cells
- pharmaceutical composition
- pharmaceutically acceptable
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020180136107A KR102147802B1 (ko) | 2018-11-07 | 2018-11-07 | 신규 화합물 및 칼시뉴린 억제제를 포함하는 이식 거부 반응 또는 이식 거부 질환의 예방 및 치료용 조성물 |
| KR10-2018-0136107 | 2018-11-07 | ||
| PCT/KR2019/015055 WO2020096371A1 (ko) | 2018-11-07 | 2019-11-07 | 신규 화합물 및 칼시뉴린 억제제를 포함하는 이식 거부 반응 또는 이식 거부 질환의 예방 및 치료용 조성물 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022513590A JP2022513590A (ja) | 2022-02-09 |
| JP2022513590A5 true JP2022513590A5 (https=) | 2022-10-20 |
| JP7470683B2 JP7470683B2 (ja) | 2024-04-18 |
Family
ID=70612506
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021524277A Active JP7470683B2 (ja) | 2018-11-07 | 2019-11-07 | 新規な化合物およびカルシニューリン阻害剤を含む、移植拒絶反応または移植拒絶疾患を予防および治療するための組成物 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US11969397B2 (https=) |
| EP (1) | EP3878443A4 (https=) |
| JP (1) | JP7470683B2 (https=) |
| KR (1) | KR102147802B1 (https=) |
| CN (1) | CN113194936A (https=) |
| AU (1) | AU2019377749B2 (https=) |
| CA (1) | CA3118881A1 (https=) |
| WO (1) | WO2020096371A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11554139B2 (en) * | 2019-05-17 | 2023-01-17 | Tolerogenixx Gmbh | MIC therapy for specific immunosuppression in transplantation |
| CN115843745A (zh) * | 2021-09-26 | 2023-03-28 | 泰州迈博太科药业有限公司 | 一种人源化肠炎小鼠模型的构建方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8637038B2 (en) | 2011-04-12 | 2014-01-28 | Rigel Pharmaceuticals, Inc. | Methods for inhibiting allograft rejection |
| US10369121B2 (en) | 2013-08-23 | 2019-08-06 | The Catholic University Of Korea Industry-Academic Cooperation Foundation | Pharmaceutical composition for preventing or treating immune diseases or inflammatory diseases, containing biguanide derivative compound as active ingredient |
| JP6462002B2 (ja) | 2014-04-29 | 2019-01-30 | ザ カトリック ユニバーシティ オブ コリア インダストリー−アカデミック コーオペレイション ファウンデーション | 免疫疾患治療効果を有する新規化合物およびその使用 |
| WO2015167243A1 (ko) * | 2014-04-29 | 2015-11-05 | 가톨릭대학교 산학협력단 | 면역질환 치료효과를 갖는 신규한 화합물 및 이의 용도 |
| KR101613371B1 (ko) | 2014-11-10 | 2016-04-18 | 가톨릭대학교 산학협력단 | 면역질환 치료효과를 갖는 신규한 화합물 및 이의 용도 |
| KR101760510B1 (ko) | 2014-12-18 | 2017-07-21 | 가톨릭대학교 산학협력단 | 메트포민을 포함하는 면역억제제로 인한 신장 독성 완화용 조성물 및 이를 포함하는 면역질환 예방 또는 치료용 조성물 |
| KR20180038355A (ko) | 2016-10-06 | 2018-04-16 | 서울과학기술대학교 산학협력단 | 탄성 및 기계적 물성이 우수한 탄성 고분자-세라믹 하이브리드 필름 및 이의 제조방법 |
| KR20190045513A (ko) | 2017-10-24 | 2019-05-03 | 가톨릭대학교 산학협력단 | Sd282 화합물 또는 칼시뉴린 억제제를 포함하는 이식 거부 반응 또는 이식 후 면역 질환의 예방 및 치료용 조성물 |
-
2018
- 2018-11-07 KR KR1020180136107A patent/KR102147802B1/ko active Active
-
2019
- 2019-11-07 AU AU2019377749A patent/AU2019377749B2/en active Active
- 2019-11-07 CN CN201980073598.8A patent/CN113194936A/zh active Pending
- 2019-11-07 US US17/290,637 patent/US11969397B2/en active Active
- 2019-11-07 JP JP2021524277A patent/JP7470683B2/ja active Active
- 2019-11-07 EP EP19882758.6A patent/EP3878443A4/en active Pending
- 2019-11-07 WO PCT/KR2019/015055 patent/WO2020096371A1/ko not_active Ceased
- 2019-11-07 CA CA3118881A patent/CA3118881A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kirsch et al. | Survival after biventricular mechanical circulatory support: does the type of device matter? | |
| CA2894417C (en) | Treatment or prevention of cardiovascular events via the administration of a colchicine derivative | |
| ES2250154T3 (es) | Agentes que inhiben las reacciones de rechazo cronico despues de un transplante de organo. | |
| CA3172535A1 (en) | Cyclophilin inhibitors and uses thereof | |
| JP2022513590A5 (https=) | ||
| JP2017529357A (ja) | 抗菌薬としての金（ｉ）−ホスフィン化合物 | |
| JP2007537299A5 (https=) | ||
| RU2008139988A (ru) | Применение производных 3,5-втор-4-норхолестана для получения лекарственного средства-цитопротектора | |
| CN116392464A (zh) | 乳酸盐在制备骨修复、骨髓间充质干细胞成骨分化的药物中的用途 | |
| EP4684781A1 (en) | Use of small-molecule compound having naphthylamine structure | |
| RU2010103320A (ru) | Противовоспалительная композиция | |
| US20180125880A1 (en) | Composition for treating tissue lesions | |
| JP2019502667A (ja) | 抗菌化合物 | |
| CN101506145B (zh) | 氨基醇衍生物以及将它们作为有效成分的免疫抑制剂 | |
| JP2008509210A5 (https=) | ||
| US20210353767A1 (en) | Compositions and methods for drug delivery | |
| CA3118881A1 (en) | Composition for preventing and treating transplant rejection or transplant rejection diseases, comprising novel compound and calcineurin inhibitor | |
| JP6878418B2 (ja) | 移植片拒絶反応の処置方法 | |
| JP6342585B2 (ja) | ４−フルオロ−チオ含有ａｐｐ２阻害剤、その組成物、および使用方法 | |
| WO2007134908A3 (en) | Use of thymosin alpha 1 for the treatment of immunological diseases | |
| JP4235000B2 (ja) | 糸球体疾患治療剤 | |
| CA3210962A1 (en) | Cxcl8 inhibitor and pharmaceutical composition thereof for use in the treatment of seizures | |
| CN109223778B (zh) | C24h24n6o2s3在制备抗结核菌药物中的用途 | |
| KR101445175B1 (ko) | 중간엽 줄기세포의 혈관내피세포로의 분화 유도를 위한 티아졸기를 함유하는 우레아 화합물 | |
| US20190255117A1 (en) | Synoviolin expression inhibitor containing mesenchymal stem cell or culture supernatant thereof |